Notice Number: NOT-HL-16-450
Release Date: September 19, 2016
National Heart, Lung, and Blood Institute (NHLBI)
The purpose of this Notice to inform potential applicants that NHLBI has posted a set of answers to Frequently Asked Questions (FAQs) regarding application for PAR-16-405 "Single-Site Investigator-Initiated Clinical Trials (R61/R33)".
The Frequently Asked Questions are available at this site:
In addition, information on NHLBI Research Support Mechanisms for Clinical Trials is available at:
While not required, all applicants are encouraged to view the FAQs prior to submitting their application.
Please direct all inquiries to: